High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence

CD8 T-cell response efficiency critically depends on the TCR binding strength to peptide-MHC, i.e., the TCR binding avidity. A current challenge in onco-immunology lies in the evaluation of vaccine protocols selecting for tumor-specific T-cells of highest avidity, offering maximal immune protection...

Full description

Bibliographic Details
Main Authors: Laura Carretero-Iglesia, Barbara Couturaud, Petra Baumgaertner, Julien Schmidt, Hélène Maby-El Hajjami, Daniel E. Speiser, Michael Hebeisen, Nathalie Rufer
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.03016/full

Similar Items